{
    "clinical_study": {
        "@rank": "43752", 
        "brief_summary": {
            "textblock": "To evaluate the efficacy of oral acyclovir for the treatment and suppression of Epstein-Barr\n      virus (EBV) related hairy leukoplakia (HL). To determine the long-term safety of acyclovir\n      in the AIDS-related complex (ARC) patient with HL. To monitor the progression of HIV disease\n      in the HL patient and compare to existing historical control data."
        }, 
        "brief_title": "Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)", 
        "condition": [
            "Leukoplakia, Hairy", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Leukoplakia", 
                "Leukoplakia, Hairy"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Topical antifungal therapy.\n\n        Patient must have:\n\n          -  Newly diagnosed clinical and histological hairy leukoplakia.\n\n          -  Positive HIV antibody by licensed ELISA or Western blot.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with AIDS or a history of intolerance or allergy to acyclovir are excluded.\n\n        Concurrent Medication:\n\n        Excluded within 2 weeks of study entry:\n\n          -  Systemic antifungal treatment.\n\n          -  Excluded within 6 weeks of study entry:\n\n          -  Immunomodulators.\n\n          -  Systemic antiviral treatment.\n\n        Patients with AIDS or a history of intolerance or allergy to acyclovir are excluded.\n\n        Prior Medication:\n\n        Excluded within 2 weeks of study entry:\n\n          -  Systemic antifungal.\n\n          -  Excluded within 6 weeks of study entry:\n\n          -  Immunomodulators.\n\n          -  Systemic antiviral treatment.\n\n          -  Excluded within 8 weeks of study entry:\n\n          -  Zidovudine (AZT) or other antiretroviral therapy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002026", 
            "org_study_id": "033A", 
            "secondary_id": "179"
        }, 
        "intervention": {
            "intervention_name": "Acyclovir", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Acyclovir"
        }, 
        "keyword": [
            "AIDS-Related Opportunistic Infections", 
            "Leukoplakia, Oral", 
            "Herpesvirus 4, Human", 
            "Acyclovir", 
            "AIDS-Related Complex"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "900331079"
                }, 
                "name": "Univ of Southern California / LA County USC Med Ctr"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "reference": {
            "PMID": "2808791", 
            "citation": "Herbst JS, Morgan J, Raab-Traub N, Resnick L. Comparison of the efficacy of surgery and acyclovir therapy in oral hairy leukoplakia. J Am Acad Dermatol. 1989 Oct;21(4 Pt 1):753-6."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002026"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Glaxo Wellcome", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 1990"
    }, 
    "geocoordinates": {
        "Univ of Southern California / LA County USC Med Ctr": "34.052 -118.244"
    }
}